Aragen's new cell line development and early manufacturing platform, CHOMax, can cut timelines to approximately 10 months.

Johnson & Johnson's agreement with the Trump administration enables patients to access drugs at a comparable price to other ...

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

Eli Lilly and Company has entered a definitive agreement to acquire Ventyx Biosciences Inc., a San Diego-based clinical-stage ...

Novo Nordisk’s International Operations business unit has committed to use Veeva Vault CRM, joining the ranks of other major ...

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...

Halozyme Therapeutics Inc. and Skye Bioscience Inc. have entered a non-exclusive global collaboration and license agreement.

ProBioGen has signed a Master Service Agreement with Zag Bio Inc., a biotechnology company developing thymus-targeted ...

Patient access to innovative new therapies requires us to reimagine the supply chain and how it integrates advanced ...

GeneDx, a rare disease diagnosis company, has appointed Linda Genen, MD, MPH as Chief Medical Officer to strengthen the ...